v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current Assets:    
Cash $ 390,951
Prepaid expenses 167,145 34,806
Total Current Assets 558,096 34,806
Cash held in trust 174,798,579
Deferred offering costs 104,903
Total Assets 175,356,675 139,709
Current Liabilities:    
Accrued offering costs 97,835
Accrued expenses 19,832
Total Current Liabilities 64,683 153,585
Deferred underwriting commission 6,000,000
Total Liabilities 6,064,683 153,585
Commitments and contingencies (Note 6)
Class A ordinary shares, $0.0001 par value; 17,250,000 shares subject to possible redemption at $10.13 per share 174,798,579
Shareholders’ Deficit:    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 24,425
Accumulated deficit (5,507,209) (38,876)
Total Shareholders’ Deficit (5,506,587) (13,876)
Total Liabilities and Shareholders’ Deficit 175,356,675 139,709
Related Party    
Current Liabilities:    
Related party payable 44,851 55,750
Class A Ordinary Shares    
Shareholders’ Deficit:    
Common Stock, Value 47
Class B Ordinary Shares    
Shareholders’ Deficit:    
Common Stock, Value [1] $ 575 $ 575
[1] Includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5). The underwriter fully exercised the over-allotment option on April 8, 2026. As such, no Class B ordinary shares were forfeited. On March 31, 2026, the Sponsor surrendered, for no consideration, 3,833,333 founder shares. Amounts have been retroactively restated to reflect the surrendered shares.